These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7158240)

  • 1. [Epidemiological significance, clinico-morphological evaluation and behavior of pathogenetic factors, in asymptomatic chronic carriers of the HBsAg in the La Plata area. Study in voluntary blood donors].
    Jmelnitzky A; Basualdo JA; Landoni N; Ponce de León H; Morales V; Chopita N; Doria I; Fink N; Barbetti A; Castelletto R; Veron M; de Torre R
    Acta Gastroenterol Latinoam; 1982; 12(2):117-34. PubMed ID: 7158240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term course in asymptomatic carriers of HBsAg in an area of low prevalence of hepatocarcinoma].
    Jmelnitzky A; Basualdo JA; Castelletto R; Mon JC; Belloni P; Rondina A; García C
    Acta Gastroenterol Latinoam; 1989; 19(1):21-30. PubMed ID: 2481374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical, laboratory and liver histology of HBsAg-positive volunteer blood donors in Belo Horizonte, State of Minas Gerais, Brazil].
    Paz MO; Galizzi Filho J; Simonetti JP; Simonetti SR; de Santana ZM; Barbosa MM; de Carvalho DG; Toppa NH
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(6):311-6. PubMed ID: 10413947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HLA antigens in blood donors, asymptomatic chronic carriers of the viral hepatitis type B surface antigen (HBsAg)].
    Morales VH; Barbetti A; Basualdo JA; Jmelnitzky A; Landoni N; Ponce de León H; Chopita N; de Torres RA
    Medicina (B Aires); 1983; 43(2):175-80. PubMed ID: 6664285
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood donors with positive HBsAg in Asturias: its current prevalence and significance].
    Suárez A; Riestra S; Navascués CA; Sotorrío NG; Rodríguez M; Tévar F; Pérez R; Sala P; Rodrigo L
    Med Clin (Barc); 1994 Mar; 102(9):329-32. PubMed ID: 8164459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
    Koçak N; Ozen H; Yüce A; Gürakan F
    Turk J Pediatr; 1998; 40(3):365-72. PubMed ID: 9763900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A prospective histologic and immunohistochemical study of the liver in blood donors who are asymptomatic chronic carriers of HBs antigens. Apropos of 34 cases].
    Ben Rejeb A; Khediri F; Ebdelli N; Bouali R; Ben Ahmed F
    Ann Gastroenterol Hepatol (Paris); 1994 Sep; 30(4):157-62. PubMed ID: 7979147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic asymptomatic HBSAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV.
    De Franchis R; D'Arminio A; Vecchi M; Ronchi G; Del Ninno E; Parravicini A; Ferroni P; Zanetti AR
    Gastroenterology; 1980 Sep; 79(3):521-7. PubMed ID: 7429112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for circulating immune complexes in blood donors as an effective method of further HBsAg carriers detection.
    Pintera J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):455-61. PubMed ID: 6169608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis B surface and e antigens, risk factors for viral acquisition and serum transaminase among blood donors in Ibadan, Nigeria.
    Otegbayo JA; Fasola FA; Abja A
    Trop Gastroenterol; 2003; 24(4):196-7. PubMed ID: 15164531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative analysis of blood donors with antibodies to the hepatitis C virus, positivity for the hepatitis B surface antigen and hypertransaminasemia in Asturias].
    Suárez A; Riestra S; Rodríguez M; Linares A; Otero L; Rodrigo L
    Med Clin (Barc); 1994 Jul; 103(6):209-13. PubMed ID: 7967864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.
    Yalçin K; Değertekin H; Alp MN; Tekeş S; Satici O; Budak T
    Turk J Gastroenterol; 2003 Sep; 14(3):157-63. PubMed ID: 14655057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic hepatitis B antigen carriers: a clinicopathological study.
    Fainaru M; Levij IS
    Acta Hepatogastroenterol (Stuttg); 1974 Jun; 21(3):186-91. PubMed ID: 4450978
    [No Abstract]   [Full Text] [Related]  

  • 17. HBsAg carriers among blood donors in Italy; a retrospective survey of data from 189 blood banks.
    Giusti G; Galanti B; Gaeta GB; Piccinino F; Ruggiero G
    Hepatogastroenterology; 1981 Apr; 28(2):96-8. PubMed ID: 7216155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases.
    Dragosics B; Ferenci P; Hitchman E; Denk H
    Hepatology; 1987; 7(2):302-6. PubMed ID: 3557309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of prospective follow-up cohort study in diagnosis and treatment of primary hepatic cancer among HBsAg carriers].
    Lu P; Wang J; Wu Y
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):856-9. PubMed ID: 11702680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.